| 常用名 | 伊多塞班对甲苯磺酸盐 | CAS号 | 480449-71-6 |
|---|---|---|---|
| 价格 | ¥需询单/100g ¥需询单/1kg ¥需询单/10kg ¥需询单/25kg | 纯度 | 98.0% |
| 备货期 | 7天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:Target: factor XaEdoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses[1].in vitro: Edoxaban PK was not affected by concomitant low-dose ASA or naproxen, but high-dose ASA increased systemic exposure of edoxaban by approximately 30%. The effects of edoxaban on prothrombin time, activated partial thromboplastin time, international normalized ratio, anti-FXa, and intrinsic FXa activity were not influenced by administration with ASA or naproxen. Inhibition of platelet aggregation by high-dose ASA, low-dose ASA, or naproxen was not affected by edoxaban[1].in vivo: Forty-eight subjects, aged 18 to 45 years, received either edoxaban 60 mg once daily × 7 days (n = 24) or digoxin 0.25 mg twice daily × 2 days and once daily × 5 days (n = 24) and then concomitantly for 7 days. Serial blood and urine samples were collected for digoxin and edoxaban concentrations on days 7 and 14. Serial coagulation assays were measured for edoxaban on days 7 and 14. Edoxaban PK parameters demonstrated mild increases in area under the curve and peak concentrations of 9.5% and 15.6%, respectively[2],Clinical trial: Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans was reported[3]. 物理化学性质: CAS号:480449-71-6 常用中文名:伊多塞班对甲苯磺酸盐 常用英文名:edoxaban tosylate 分子式:C31H38ClN7O7S2 分子量:720.259 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8℃ |